| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 144, Issue 1 7-15, Copyright © 1990 by American Association of Immunologists
ARTICLES |
SM Denning, PT Le, KH Singer and BF Haynes
Department of Medicine, Duke University Medical Center, Durham, NC 27710.
The CD44 inhibitor Lutheran [In(Lu)]-related p80 molecule has recently been shown to be identical to the Hermes-1 lymphocyte homing receptor and to the human Pgp-1 molecule. We have determined the effect of addition of CD44 antibodies to in vitro activation assays of PBMC. CD44 antibodies did not induce PBMC proliferation alone, but markedly enhanced PBMC proliferation induced by a mitogenic CD2 antibody pair or by CD3 antibody. CD44 antibody addition had no effect upon PBMC activation induced by PHA or tetanus toxoid. CD44 antibody enhancement of CD2 antibody-induced T cell activation was specific for mature T cells as thymocytes could not be activated in the presence of combinations of CD2 and CD44 antibodies. CD44 antibody enhancement of CD2-mediated T cell triggering occurred if CD44 antibody was placed either on monocytes or on T cells. In experiments with purified monocyte and T cell suspensions, CD44 antibodies A3D8 and A1G3 augmented CD2-mediated T cell activation by three mechanisms. First, CD44 antibody binding to monocytes induced monocyte IL-1 release, second, CD44 antibodies enhanced the adhesion of T cells and monocytes in CD2 antibody-stimulated cultures, and third, CD44 antibodies augmented T cell IL-2 production in response to CD2 antibodies. Thus, ligand binding to CD44 molecules on T cells and monocytes may regulate numerous events on both cell types that are important for T cell activation. Given that recent data suggest that the CD44 molecule may bind to specific ligands on endothelial cells (vascular addressin) and within the extracellular matrix (collagen, fibronectin), these data raise the possibility that binding of T cells to endothelial cells or extracellular matrix proteins may induce or up-regulate T cell activation in inflammatory sites.
This article has been cited by other articles:
|
|
 |
|
  V. L. Hegde, N. P. Singh, P. S. Nagarkatti, and M. Nagarkatti CD44 mobilization in allogeneic dendritic cell-T cell immunological synapse plays a key role in T cell activation J. Leukoc. Biol., July 1, 2008; 84(1): 134 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Gadhoum, M.-P. Leibovitch, J. Qi, D. Dumenil, L. Durand, S. Leibovitch, and F. Smadja-Joffe CD44: a new means to inhibit acute myeloid leukemia cell proliferation via p27Kip1 Blood, February 1, 2004; 103(3): 1059 - 1068. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Do, A. Q. Rafi-Janajreh, R. J. Mckallip, P. S. Nagarkatti, and M. Nagarkatti Combined deficiency in CD44 and Fas leads to exacerbation of lymphoproliferative and autoimmune disease Int. Immunol., November 1, 2003; 15(11): 1327 - 1340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Khaldoyanidi, S. Karakhanova, J. Sleeman, P. Herrlich, and H. Ponta CD44 variant-specific antibodies trigger hemopoiesis by selective release of cytokines from bone marrow macrophages Blood, May 13, 2002; 99(11): 3955 - 3961. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Suzuki, H. Kobayashi, M. Fujie, T. Nishida, M. Takigawa, N. Kanayama, and T. Terao Kunitz-type Protease Inhibitor Bikunin Disrupts Phorbol Ester-induced Oligomerization of CD44 Variant Isoforms Containing Epitope v9 and Subsequently Suppresses Expression of Urokinase-type Plasminogen Activator in Human Chondrosarcoma Cells J. Biol. Chem., March 1, 2002; 277(10): 8022 - 8032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.-S. Charrad, Z. Gadhoum, J. Qi, A. Glachant, M. Allouche, C. Jasmin, C. Chomienne, and F. Smadja-Joffe Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines Blood, January 1, 2002; 99(1): 290 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Blass, E. Pure, and C. A. Hunter A Role for CD44 in the Production of IFN-{{gamma}} and Immunopathology During Infection with Toxoplasma gondii J. Immunol., May 1, 2001; 166(9): 5726 - 5732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Allouche, R. S. Charrad, A. Bettaieb, C. Greenland, C. Grignon, and F. Smadja-Joffe Ligation of the CD44 adhesion molecule inhibits drug-induced apoptosis in human myeloid leukemia cells Blood, August 1, 2000; 96(3): 1187 - 1190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Drillenburg and S. T. Pals Cell adhesion receptors in lymphoma dissemination Blood, March 15, 2000; 95(6): 1900 - 1910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Seiter, D.-S. Schmidt, and M. Zoller The CD44 variant isoforms CD44v6 and CD44v7 are expressed by distinct leukocyte subpopulations and exert non-overlapping functional activities Int. Immunol., January 1, 2000; 12(1): 37 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. L. W. Van Hal, G. A. M. S. Van Dongen, C. B. M. Ten Brink, K.-H. Heider, I. Rech-Weichselbraun, G. B. Snow, and R. H. Brakenhoff Evaluation of Soluble CD44v6 as a Potential Serum Marker for Head and Neck Squamous Cell Carcinoma Clin. Cancer Res., November 1, 1999; 5(11): 3534 - 3541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. de la Motte, V. C. Hascall, A. Calabro, B. Yen-Lieberman, and S. A. Strong Mononuclear Leukocytes Preferentially Bind via CD44 to Hyaluronan on Human Intestinal Mucosal Smooth Muscle Cells after Virus Infection or Treatment with Poly(I{middle dot}C) J. Biol. Chem., October 22, 1999; 274(43): 30747 - 30755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ishiwatari-Hayasaka, T. Fujimoto, T. Osawa, T. Hirama, N. Toyama-Sorimachi, and M. Miyasaka Requirements for Signal Delivery Through CD44: Analysis Using CD44-Fas Chimeric Proteins J. Immunol., August 1, 1999; 163(3): 1258 - 1264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. KNOFLACH, H. AZUMA, C. MAGEE, M. DENTON, B. MURPHY, A. IYENGAR, R. BUELOW, and M. H. SAYEGH Immunomodulatory Functions of Low-Molecular Weight Hyaluronate in an Acute Rat Renal Allograft Rejection Model J. Am. Soc. Nephrol., May 1, 1999; 10(5): 1059 - 1066. [Abstract] [Full Text]
|
|
|
|
|
|
K. Fujii, Y. Tanaka, S. Hubscher, K. Saito, T. Ota, and S. Eto Cross-Linking of CD44 on Rheumatoid Synovial Cells Up-Regulates VCAM-1 J. Immunol., February 15, 1999; 162(4): 2391 - 2398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Wolff, B. Greenfield, D. D. Taub, W. J. Murphy, K. L. Bennett, and A. Aruffo Generation of Artificial Proteoglycans Containing Glycosaminoglycan-modified CD44. DEMONSTRATION OF THE INTERACTION BETWEEN RANTES AND CHONDROITIN SULFATE J. Biol. Chem., January 22, 1999; 274(4): 2518 - 2524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Haegel-Kronenberger, H. de la Salle, A. Bohbot, F. Oberling, J.-P. Cazenave, and D. Hanau Adhesive and/or Signaling Functions of CD44 Isoforms in Human Dendritic Cells J. Immunol., October 15, 1998; 161(8): 3902 - 3911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rachmilewitz and M. L. Tykocinski Differential Effects of Chondroitin Sulfates A and B on Monocyte and B-Cell Activation: Evidence for B-Cell Activation Via a CD44-Dependent Pathway Blood, July 1, 1998; 92(1): 223 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ilangumaran, A. Briol, and D. C. Hoessli CD44 Selectively Associates With Active Src Family Protein Tyrosine Kinases Lck and Fyn in Glycosphingolipid-Rich Plasma Membrane Domains of Human Peripheral Blood Lymphocytes Blood, May 15, 1998; 91(10): 3901 - 3908. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. P. Skelton, C. Zeng, A. Nocks, and I. Stamenkovic Glycosylation Provides Both Stimulatory and Inhibitory Effects on Cell Surface and Soluble CD44 Binding to Hyaluronan J. Cell Biol., January 26, 1998; 140(2): 431 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schmits, J. Filmus, N. Gerwin, G. Senaldi, F. Kiefer, T. Kundig, A. Wakeham, A. Shahinian, C. Catzavelos, J. Rak, et al. CD44 Regulates Hematopoietic Progenitor Distribution, Granuloma Formation, and Tumorigenicity Blood, September 15, 1997; 90(6): 2217 - 2233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Griffioen, M. J.H. Coenen, C. A. Damen, S. M.M. Hellwig, D. H.J. van Weering, W. Vooys, G. H. Blijham, and G. Groenewegen CD44 Is Involved in Tumor Angiogenesis; an Activation Antigen on Human Endothelial Cells Blood, August 1, 1997; 90(3): 1150 - 1159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zoller, A. Schmidt, A. Denzel, and J. Moll Constitutive Expression of a CD44 Variant Isoform on T Cells Facilitates Regaining of Immunocompetence in Allogeneic Bone Marrow Transplantation Blood, July 15, 1997; 90(2): 873 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Weiss, J. Sleeman, A. C. Renkl, H. Dittmar, C. C. Termeer, S. Taxis, N. Howells, M. Hofmann, G. Kohler, E. Schopf, et al. An Essential Role for CD44 Variant Isoforms in Epidermal Langerhans Cell and Blood Dendritic Cell Function J. Cell Biol., June 2, 1997; 137(5): 1137 - 1147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Rafi, M. Nagarkatti, and P. S. Nagarkatti Hyaluronate-CD44 Interactions Can Induce Murine B-Cell Activation Blood, April 15, 1997; 89(8): 2901 - 2908. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Taylor, C. Gercel-Taylor, and S. A. Gall Expression and Shedding of CD44 Variant Isoforms in Patients With Gynecologic Malignancies Reproductive Sciences, September 1, 1996; 3(5): 289 - 294. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Murakami, T. Saho, A. Asari, E. Hino, D. Kasai, Y. Shimabukuro, and H. Okada CD44-Hyaluronate Interaction Participates in the Adherence of T-lymphocytes to Gingival Fibroblasts Journal of Dental Research, August 1, 1996; 75(8): 1545 - 1552. [Abstract] [PDF]
|
|
|
|
|
|
M. J. Telen, M. Udani, M. K. Washington, M. C. Levesque, E. Lloyd, and N. Rao A Blood Group-related Polymorphism of CD44 Abolishes a Hyaluronan-binding Consensus Sequence without Preventing Hyaluronan Binding J. Biol. Chem., March 22, 1996; 271(12): 7147 - 7153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. I. Taher, L. Smit, A. W. Griffioen, E. J. M. Schilder-Tol, J. Borst, and S. T. Pals Signaling through CD44 Is Mediated by Tyrosine Kinases J. Biol. Chem., February 2, 1996; 271(5): 2863 - 2867. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Toyama-Sorimachi, H. Sorimachi, Y. Tobita, F. Kitamura, H. Yagita, K. Suzuki, and M. Miyasaka A Novel Ligand for CD44 Is Serglycin, a Hematopoietic Cell Lineage-specific Proteoglycan J. Biol. Chem., March 31, 1995; 270(13): 7437 - 7444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Bartolazzi, D Jackson, K Bennett, A Aruffo, R Dickinson, J Shields, N Whittle, and I Stamenkovic Regulation of growth and dissemination of a human lymphoma by CD44 splice variants J. Cell Sci., January 4, 1995; 108(4): 1723 - 1733. [Abstract] [PDF]
|
|
|
|
|
|
C. Underhill CD44: the hyaluronan receptor J. Cell Sci., October 1, 1992; 103(2): 293 - 298. [PDF]
|
|
|
|
 |
|
 R Arch, K Wirth, M Hofmann, H Ponta, S Matzku, P Herrlich, and M Zoller Participation in normal immune responses of a metastasis-inducing splice variant of CD44 Science, July 31, 1992; 257(5070): 682 - 685. [Abstract] [PDF]
|
|
|
|
|
|
D. Webb, Y Shimizu, G. Van Seventer, S Shaw, and T. Gerrard LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release Science, September 14, 1990; 249(4974): 1295 - 1297. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
